|Dr. Rick Mangat Ph.D.||Co-Founder, Pres, CEO & Director||689.59k||N/A||N/A|
|Mr. Roger Deck CPA, CA||Chief Financial Officer||465.31k||N/A||N/A|
|Mr. Derrick Guo J.D., CPA, CA||Gen. Counsel & Corp. Sec.||325.8k||N/A||N/A|
|Mr. Thomas Tamberrino MBA||VP of Sales & Marketing||427.2k||N/A||N/A|
|Ms. Lori Swalm||Sr. VP of Regulatory, Clinical & Economic Affairs||342.45k||N/A||N/A|
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the United States and internationally. The company offers SPY Elite, a fluorescence imaging system that enables surgeons performing open procedures, such as breast and other reconstruction, gastrointestinal, and cardiothoracic surgery, to visualize microvascular blood flow and perfusion in tissue intraoperatively. It also provides PINPOINT endoscopic fluorescence imaging systems; LUNA fluorescence angiography system that provides clinicians with real-time visualization of tissue perfusion in patients; and Dermacell, a decellularized regenerative human tissue matrix that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds. Novadaq Technologies Inc. has alliances with Intuitive Surgical, Inc.; LifeNet Health; MAQUET Getinge Group; and Arthrex, Inc. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
Novadaq Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.